SK Chemicals & Lilly Korea sign co-marketing agreement of Cymbalta

On the 15^th, SK Chemicals announced it signed a co-marketing agreement of the osteoarthritis pain treatment ‘Cymbalta(generic name: Duloxetine Hcl)’ for patients that have adverse reactions to antidepressants and nonsteroidal anti-inflammatory drugs(NSAIDs) with Lilly Korea.

Under the agreement, SK Chemicals will take charge in marketing and sales from January 1 2017 for the Cymbalta’s pain-re...